Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Assets: 2020-2024

Historic Assets for Relay Therapeutics (RLAY) over the last 5 years, with Dec 2024 value amounting to $871.3 million.

  • Relay Therapeutics' Assets fell 27.97% to $670.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $670.0 million, marking a year-over-year decrease of 27.97%. This contributed to the annual value of $871.3 million for FY2024, which is 3.24% up from last year.
  • According to the latest figures from FY2024, Relay Therapeutics' Assets is $871.3 million, which was up 3.24% from $844.0 million recorded in FY2023.
  • In the past 5 years, Relay Therapeutics' Assets ranged from a high of $1.1 billion in FY2022 and a low of $799.8 million during FY2020.
  • For the 3-year period, Relay Therapeutics' Assets averaged around $938.3 million, with its median value being $871.3 million (2024).
  • Per our database at Business Quant, Relay Therapeutics' Assets grew by 26.08% in 2021 and then fell by 23.26% in 2023.
  • Over the past 5 years, Relay Therapeutics' Assets (Yearly) stood at $799.8 million in 2020, then climbed by 26.08% to $1.0 billion in 2021, then rose by 9.06% to $1.1 billion in 2022, then fell by 23.26% to $844.0 million in 2023, then climbed by 3.24% to $871.3 million in 2024.